NABRIVA THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NBRVF and buy or sell other stocks, ETFs, and their options commission-free!About NBRVF
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
CEOH. Michael Hogan
CEOH. Michael Hogan
Employees39
Employees39
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees39
Employees39
NBRVF Key Statistics
Market cap323.08
Market cap323.08
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume51.67
Average volume51.67
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume409.00
Volume409.00
52 Week high$0.0002
52 Week high$0.0002
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 323.08, NABRIVA THERAPEUTICS(NBRVF) trades at $0.00.
On 2026-06-08, NABRIVA THERAPEUTICS(NBRVF) stock traded between a low of $0.00 and a high of $0.00. Shares are currently priced at $0.00, which is 0.0% above the low and 0.0% below the high.
NABRIVA THERAPEUTICS(NBRVF) shares are trading with a volume of 409, against a daily average of 51.67.
During the past year, NABRIVA THERAPEUTICS(NBRVF) stock moved between $0.00 at its lowest and $0.00 at its peak.
During the past year, NABRIVA THERAPEUTICS(NBRVF) stock moved between $0.00 at its lowest and $0.00 at its peak.
Analyst ratings
83%
of 6 ratingsBuy
16.7%
Hold
83.3%
Sell
0%
People also own
Based on the portfolios of people who own NBRVF. This list is generated using Robinhood data, and it’s not a recommendation.